J&J Medical Connect
IMAAVY™

(nipocalimab-aahu)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

IMAAVY™ (nipocalimab-aahu)

Patient Medical Information

How Will I Receive IMAAVY?

Last Updated: 05/01/2025

summary

Here is a passage from the IMAAVY PATIENT INFORMATION which may be helpful to address your question:

How will I receive IMAAVY?

  • IMAAVY will be given to you by your healthcare provider through a needle placed into your vein (intravenous [IV] infusion).1
  • You will receive a starting dose of IMAAVY infusion lasting at least 30 minutes. Two weeks later, you will receive your next dose of IMAAVY infusion lasting at least 15 minutes. Your following doses will be given every two weeks.1
  • If you have a reaction during your IMAAVY infusion, your healthcare provider may decide to give IMAAVY more slowly or to stop your infusion.1
  • If you miss a scheduled IMAAVY infusion, you should receive your next dose as soon as possible.1

ADDITIONAL INFORMATION

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT INFORMATION for IMAAVY.1

 

References

1 IMAAVY (nipocalimab-aahu) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/IMAAVY-pi.pdf